Boris Charchyan

Boris Charchyan is a seasoned pharmaceutical executive with extensive experience in leadership roles across Russia and the CIS region. Currently serving as Regional CEO and Area General Manager at Aspen Pharma Group since September 2019, Charchyan previously held positions including Business Unit Director for Insulin at Novo Nordisk and Chief Commercial Officer at Biologische Heilmittel Heel GmbH. Additional experience includes General Manager for Russia and neighboring countries at ViiV Healthcare, Regional Director at GSK, and various leadership roles at Astellas Pharma. Charchyan holds an MBA in Marketing and Sales from The Russian Presidential Academy of National Economy and Public Administration and a Master's degree in Economics from the Russian Foreign Trade Academy.